DNMT3B<i>in vitro</i>knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation
Francesca Megiorni(Sapienza University of Rome), Carlo Dominici(Sapienza University of Rome)
Cited by 40
Related Papers
Crizotinib-induced antitumour activity in human alveolar rhabdomyosarcoma cells is not solely dependent on ALK and MET inhibition
|Journal of Experimental & Clinical Cancer Research|2015|55
Clinical and Molecular Evidence for c-kit Receptor as a Therapeutic Target in Neuroblastic Tumors
|Clinical Cancer Research|2005|38
PARP inhibitors affect growth, survival and radiation susceptibility of human alveolar and embryonal rhabdomyosarcoma cell lines
|Journal of Cancer Research and Clinical Oncology|2018|35